LONG-TERM CLINICAL OUTCOMES AND FACTORS PREDICTIVE OF RELAPSE AFTER 5-AMINOSALICYLATE OR SULFASALAZINE THERAPY IN PATIENTS WITH INTESTINAL BEHCET'S DISEASE

(1) YONSEI UNIVERSITY COLLEGE OF MEDICINE



This item was part of the Drug therapies in intestinal inflammation session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A99